Article: Nicotinamide Riboside Supplementation Supports Immune Regulation in Human Cells and Blood: Clinical Findings

Mar 5, 2024 Clinical Immune Health

Nicotinamide Riboside Supplementation Supports Immune Regulation in Human Cells and Blood: Clinical Findings

Objectives

To investigate how NR influences the migration of macrophages and the underlying mechanisms behind this effect.

Journal

Cells

Key Outcomes

Ex Vivo:

NR treatment increased levels of NAD+ and prostaglandin E2 (PGE2), a key regulator of inflammatory and immune responses, in monocytes from healthy subjects.

In Vivo:

NR supplementation increased PGE2 levels in human serum.

Duration

1 week

Dose

1000 mg

Study Design

Ex Vivo:
Monocytes were extracted from young, healthy subjects and then treated with NR

In Vivo:
Randomized, double-blind, placebo-controlled, pilot study in 36 young, healthy subjects

See Published Study

Digestive/Gut Health

Nicotinamide Riboside Ameliorates Senescence-Associated Alterations in Gastric Parietal Cells: Preclinical Findings

Synopsis Aging causes widespread cellular decline, including in the gastrointestinal (GI) tract, where reduced digestive function and nutrient absorption often occur. This study examined how aging...

Muscle Health

Effects of Nicotinamide Riboside on Spinal and Bulbar Muscular Atrophy (SBMA): Preclinical Findings

SynopsisPrevious studies have shown that in spinal and bulbar muscular atrophy (SBMA), a mutant protein called polyQ-expanded AR becomes improperly acetylated, and activating SIRT1, an NAD-dependen...